メディシノバ・インク
MediciNova IncUSUSDMediciNova Inc (US:MNOV) — Biotechnology: Pharmaceutical Preparations. Numero di borse in cui sono quotate le azioni della società: 2. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'Azienda
- Sito Web
- medicinova.com
- Relazioni con gli Investitori
- medicinova.com/ir/
- Settore
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede Centrale
- LA JOLLA, United States
- Amministratore Delegato
- Yuichi Iwaki
- Dipendenti
- 6
- Azioni in Circolazione
- Flottante
- 42.94 Mln
- Capitalizzazione di Mercato
- 11.86 Mld JPY
- Insider
- 2.86%
- Investitori Istituzionali
- 20.38%
- Settore (SIC)
- Pharmaceutical Preparations
- FCF
- −9.12 Mln USD
- Debito
- 0 USDliquidità netta
- Utili e FCF — per i 12 mesi a 30.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Principali Azionisti
| Detentore | Quota | Azioni | Data del Rapporto |
|---|---|---|---|
| Essex Woodlands Manageme… | 2.25% | 1.11 Mln | 2026-06-30 |
| Blackrock Inc. | 1.53% | 752 091 | 2026-06-30 |
| Citigroup Inc. | 1.29% | 635 715 | 2026-06-30 |
| Vanguard Capital Managem… | 1.24% | 609 052 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.24% | 609 052 | 2026-06-30 |
| Geode Capital Management… | 1.1% | 539 312 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.57% | 282 608 | 2026-06-30 |
| Fidelity Concord Street… | 0.51% | 251 205 | 2026-07-31 |
| UBS Group AG | 0.45% | 222 200 | 2026-06-30 |
| Renaissance Technologies… | 0.42% | 205 400 | 2026-06-30 |
| State Street Corporation | 0.39% | 193 698 | 2026-06-30 |
| iShares Trust-iShares Mi… | 0.32% | 157 930 | 2026-08-31 |
| Northern Trust Corporati… | 0.29% | 143 665 | 2026-06-30 |
| Fidelity Concord Street… | 0.18% | 87 575 | 2026-07-31 |
| SCHWAB CAPITAL TRUST-Sch… | 0.15% | 71 506 | 2026-07-31 |
| Fidelity Concord Street… | 0.14% | 68 406 | 2026-07-31 |
| Fidelity Concord Street… | 0.05% | 24 533 | 2026-07-31 |
| Northern Funds-SMALL CAP… | 0.03% | 13 894 | 2026-06-30 |
| EQ Advisors Trust-1290 V… | 0.02% | 10 525 | 2026-06-30 |
| LINCOLN Varbl INSURANCE… | 0.01% | 6 693 | 2026-06-30 |
| 3D INVESTMENT PARTNERS P… | — | — | 2026-09-25 |
